Acute pancreatitis resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) |
||
Line 33: | Line 33: | ||
* Inflammation associated with pancreatic parenchymal necrosis and/or peripancreatic necrosis. | * Inflammation associated with pancreatic parenchymal necrosis and/or peripancreatic necrosis. | ||
:: ''CECT criteria'' | :: ''CECT criteria'' | ||
::▸ Lack of pancreatic parenchymal enhancement by intravenous contrast agent | ::▸ Lack of pancreatic parenchymal enhancement by intravenous contrast agent. <BR> | ||
::▸ Presence of findings of peripancreatic necrosis. | |||
::▸ | =====Infected Pancreatic Necrosis===== | ||
* Peripancreatic fluid associated with interstitial oedematous pancreatitis with no associated peripancreatic necrosis. This term applies only to areas of peripancreatic fluid seen within the first 4 weeks after onset of interstitial oedematous pancreatitis and without the features of a pseudocyst. | |||
:: ''CECT criteria'' | |||
::▸ Occurs in the setting of interstitial edematous pancreatitis. <BR> | |||
::▸ Homogeneous collection with fluid density. <BR> | |||
::▸ Confined by normal peripancreatic fascial planes. <BR> | |||
::▸ No definable wall encapsulating the collection. <BR> | |||
::▸ Adjacent to pancreas (no intrapancreatic extension). | |||
* Should be considered in patients with necrotizing pancreatitis who deteriorate or fail to improve after 7–10 days of hospitalization.<ref name="Banks-2013">{{Cite journal | last1 = Banks | first1 = PA. | last2 = Bollen |first2 = TL. | last3 = Dervenis | first3 = C. | last4 = Gooszen | first4 = HG. | last5 = Johnson | first5 = CD. | last6 = Sarr | first6 = MG. | last7 = Tsiotos | first7 = GG. |last8 = Vege | first8 = SS. | last9 = Acosta | first9 = JM. | title = Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. | journal = Gut | volume = 62 | issue = 1 | pages = 102-11 | month = Jan | year = 2013 | doi = 10.1136/gutjnl-2012-302779 | PMID = 23100216 }}</ref> | * Should be considered in patients with necrotizing pancreatitis who deteriorate or fail to improve after 7–10 days of hospitalization.<ref name="Banks-2013">{{Cite journal | last1 = Banks | first1 = PA. | last2 = Bollen |first2 = TL. | last3 = Dervenis | first3 = C. | last4 = Gooszen | first4 = HG. | last5 = Johnson | first5 = CD. | last6 = Sarr | first6 = MG. | last7 = Tsiotos | first7 = GG. |last8 = Vege | first8 = SS. | last9 = Acosta | first9 = JM. | title = Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. | journal = Gut | volume = 62 | issue = 1 | pages = 102-11 | month = Jan | year = 2013 | doi = 10.1136/gutjnl-2012-302779 | PMID = 23100216 }}</ref> | ||
Revision as of 10:44, 4 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Vidit Bhargava, M.B.B.S [2]
Definition
Diagnostic Criteria
- Diagnosis is established by the presence of two of the three following criteria:[1]
- (i) Acute onset of a persistent, severe, epigastric pain often radiating to the back.
- (ii) Serum lipase or amylase ≥ 3 x ULN.
- (iii) Characteristic findings on contrast-enhanced CT, MRI, or transabdominal US.
Types of Acute Pancreatitis
Interstitial Edematous Pancreatitis
- Acute inflammation of the pancreatic parenchyma and peripancreatic tissues, but without recognizable tissue necrosis.
- CECT criteria
- ▸ Pancreatic parenchyma enhancement by intravenous contrast agent.
- ▸ No findings of peripancreatic necrosis.
Necrotizing Pancreatitis
- Inflammation associated with pancreatic parenchymal necrosis and/or peripancreatic necrosis.
- CECT criteria
- ▸ Lack of pancreatic parenchymal enhancement by intravenous contrast agent.
- ▸ Presence of findings of peripancreatic necrosis.
Infected Pancreatic Necrosis
- Peripancreatic fluid associated with interstitial oedematous pancreatitis with no associated peripancreatic necrosis. This term applies only to areas of peripancreatic fluid seen within the first 4 weeks after onset of interstitial oedematous pancreatitis and without the features of a pseudocyst.
- CECT criteria
- ▸ Occurs in the setting of interstitial edematous pancreatitis.
- ▸ Homogeneous collection with fluid density.
- ▸ Confined by normal peripancreatic fascial planes.
- ▸ Confined by normal peripancreatic fascial planes.
- ▸ No definable wall encapsulating the collection.
- ▸ Adjacent to pancreas (no intrapancreatic extension).
- ▸ No definable wall encapsulating the collection.
- Should be considered in patients with necrotizing pancreatitis who deteriorate or fail to improve after 7–10 days of hospitalization.[1]
- May be presumed by the presence of extraluminal gas on CECT or when fine-needle aspiration is positive for bacteria and/or fungi on Gram stain and culture.[2]
- Antibiotics able to penetrate pancreatic necrosis (such as carbapenems, quinolones, and metronidazole) may be useful in delaying or sometimes totally avoiding intervention.[3][4]
Local Complications
- Should be suspected when there is persistence/recurrence of abdominal pain, secondary increases in pancreatic enzyme, increasing organ dysfunction, or the development of signs of sepsis.[1]
- Acute peripancreatic fluid collection (APFC)
- Peripancreatic fluid associated with interstitial edematous pancreatitis with no associated peripancreatic necrosis.
- Pancreatic pseudocyst
- An encapsulated collection of fluid with a well defined inflammatory wall usually outside the pancreas with minimal or no necrosis.
- Acute necrotic collection (ANC)
- A collection containing variable amounts of both fluid and necrosis associated with necrotizing pancreatitis.
- Walled-off necrosis (WON)
- A mature, encapsulated collection of pancreatic and/or peripancreatic necrosis that has developed a well defined inflammatory wall.
- Others (gastric outlet dysfunction, splenic and portal vein thrombosis, colonic necrosis, etc.)
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Acute pancreatitis from any cause may be life-threatening especially if it progresses to necrotizing pancreatitis.
Common Causes
- Idiopathic
- Ischaemic necrosis of pancreas from vascular sources such as vasculitis and atherosclerosis
- Medication such as 5-mercaptopurine, azathioprine, 5-DDI[5]
- Metabolic - hypercalcemia and hyperphosphatemia
- Post - ERCP
- Pregnancy
- Toxins such as venom of brown recluse spider, certain arachnids etc.
Management
Acute Pancreatitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Signs & symptoms: severe abdominal pain, breathing difficulty, hypotension, vomiting, fever, cullen's sign, grey turner sign | Check labs - serum amylase, serum lipase, serum triglycerides, abdominal USG, CBC, CECT, MRI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic criteria: Any 2 out of 3 Abdominal pain consistent with disease serum amylase or lipase values > 3 times normal consistent findings from abdominal imaging | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Risk stratification | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Low risk* | High risk** | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
General medical ward | ICU | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Initiate supportive care Aggressive fluid resuscitation with 250-500 mlRingers Lactate per hr during first 12-24 hours In sever cases give fluid bolus Mild cases - oral liquid feeds In moderate to severe cases enteral feeds, nasogastric or nasojejunal feeds are acceptable | CT scan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Provide adequate analgesia | Pancreatic necrosis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stones? | Other causes, treat as per cause | No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Surgical consult Emergency cholecystectomy or ERCP within 24 Hrs of admission | Assess in 1 week | SIRS/Organ failure? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tolerating oral feeds | Not tolerating oral feed | If yes, surgical consultation Think about CT guided percutaneous aspiration & culture | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recovery | Add nutritional support Consider CT scan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lack of improvement/Worsening of clinical status | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- * - Low risk: 1. Absence of organ failure. and/or 2. Absence of local complications
- ** - High risk: 1. Transient organ failure. and/or 2. local complications.
The following recommendations are based on 2013 guidelines for Acute pancreatitis treatment based on recommendations given by American college of gastroenterology.[9]
Do's
- Perform abdominal USG in all patients.
- Check serum triglycerides if stones/alcohol not not an etiology.
- Consider pancreatic tumor if age > 40 yrs.
- Use Ringer's Lactate(RL) as first choice agent, use normal saline if RL not available.
- Refer patients with idiopathic acute pancreatitis to centers of excellence.
- Perform elective cholecystectomy for gallstones to prevent recurrences.
- Use antibiotics for infected necrosis, with high penetrance such as carbapenems, quinolones & metronidazole.
- CECT or MRI should be reserved for:[10][11][12]
- Patients who fail to improve clinically (e.g., persistent abdominal pain, fever, nausea, unable to begin oral intake) within the first 48-72 h after admission.
- Patients in whom the diagnosis is unclear.
Dont's
- Do not shift patients with sepsis/organ failure to general ward.
- Do not perform emergency surgery in stable patients with infected necrosis, wait for 3-4 weeks.
References
- ↑ 1.0 1.1 1.2 Banks, PA.; Bollen, TL.; Dervenis, C.; Gooszen, HG.; Johnson, CD.; Sarr, MG.; Tsiotos, GG.; Vege, SS.; Acosta, JM. (2013). "Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus". Gut. 62 (1): 102–11. doi:10.1136/gutjnl-2012-302779. PMID 23100216. Unknown parameter
|month=
ignored (help) - ↑ Banks, PA.; Gerzof, SG.; Langevin, RE.; Silverman, SG.; Sica, GT.; Hughes, MD. (1995). "CT-guided aspiration of suspected pancreatic infection: bacteriology and clinical outcome". Int J Pancreatol. 18 (3): 265–70. doi:10.1007/BF02784951. PMID 8708399. Unknown parameter
|month=
ignored (help) - ↑ Petrov, MS.; Shanbhag, S.; Chakraborty, M.; Phillips, AR.; Windsor, JA. (2010). "Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis". Gastroenterology. 139 (3): 813–20. doi:10.1053/j.gastro.2010.06.010. PMID 20540942. Unknown parameter
|month=
ignored (help) - ↑ van Santvoort, HC.; Bakker, OJ.; Bollen, TL.; Besselink, MG.; Ahmed Ali, U.; Schrijver, AM.; Boermeester, MA.; van Goor, H.; Dejong, CH. (2011). "A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome". Gastroenterology. 141 (4): 1254–63. doi:10.1053/j.gastro.2011.06.073. PMID 21741922. Unknown parameter
|month=
ignored (help) - ↑ Yi, GC.; Yoon, KH.; Hwang, JB. (2012). "Acute Pancreatitis Induced by Azathioprine and 6-mercaptopurine Proven by Single and Low Dose Challenge Testing in a Child with Crohn Disease". Pediatr Gastroenterol Hepatol Nutr. 15 (4): 272–5. doi:10.5223/pghn.2012.15.4.272. PMID 24010098. Unknown parameter
|month=
ignored (help) - ↑ Rebours, V.; Vullierme, MP.; Hentic, O.; Maire, F.; Hammel, P.; Ruszniewski, P.; Lévy, P. (2012). "Smoking and the course of recurrent acute and chronic alcoholic pancreatitis: a dose-dependent relationship". Pancreas. 41 (8): 1219–24. doi:10.1097/MPA.0b013e31825de97d. PMID 23086245. Unknown parameter
|month=
ignored (help) - ↑ Köhler, H.; Lankisch, PG. (1987). "Acute pancreatitis and hyperamylasaemia in pancreatic carcinoma". Pancreas. 2 (1): 117–9. PMID 2437571.
- ↑ Bleichner, JP.; Guillou, YM.; Martin, L.; Seguin, P.; Mallédant, Y. (1998). "-Pancreatitis after blunt injuries to the abdomen-". Ann Fr Anesth Reanim. 17 (3): 250–3. PMID 9750738.
- ↑ Tenner, S.; Baillie, J.; DeWitt, J.; Vege, SS. (2013). "American College of Gastroenterology guideline: management of acute pancreatitis". Am J Gastroenterol. 108 (9): 1400–15, 1416. doi:10.1038/ajg.2013.218. PMID 23896955. Unknown parameter
|month=
ignored (help) - ↑ Arvanitakis, M.; Delhaye, M.; De Maertelaere, V.; Bali, M.; Winant, C.; Coppens, E.; Jeanmart, J.; Zalcman, M.; Van Gansbeke, D. (2004). "Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis". Gastroenterology. 126 (3): 715–23. PMID 14988825. Unknown parameter
|month=
ignored (help) - ↑ Zaheer, A.; Singh, VK.; Qureshi, RO.; Fishman, EK. (2013). "The revised Atlanta classification for acute pancreatitis: updates in imaging terminology and guidelines". Abdom Imaging. 38 (1): 125–36. doi:10.1007/s00261-012-9908-0. PMID 22584543. Unknown parameter
|month=
ignored (help) - ↑ Bollen, TL.; Singh, VK.; Maurer, R.; Repas, K.; van Es, HW.; Banks, PA.; Mortele, KJ. (2011). "Comparative evaluation of the modified CT severity index and CT severity index in assessing severity of acute pancreatitis". AJR Am J Roentgenol. 197 (2): 386–92. doi:10.2214/AJR.09.4025. PMID 21785084. Unknown parameter
|month=
ignored (help)